Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
IUBMB Life|May 3, 2020
Cardiotoxicity danger in immunotherapyBeata Jagielska, Patrycja Ozdowska, Katarzyna Gepner, et al.
Reumatologia|November 25, 2021
Patterns of dyslipidemia in young patients with seronegative spondyloarthropathies without cardiovascular diseasesPatrycja Ozdowska, Ilona Kowalik, Krzysztof Sadowski, et al.
Polish Archives of Internal Medicine|July 31, 2018
Increased prevalence of subclinical coronary atherosclerosis in young patients with ankylosing spondylitisPatrycja Ozdowska, Łukasz Wardziak, Mariusz Kruk, et al.
Pharmaceuticals (Basel, Switzerland)|October 29, 2025
Predictive Value of Baseline Left Ventricular Global Longitudinal Strain for Cardiac Dysfunction in Patients with Moderate to High Risk of Cancer Therapy-Related Cardiovascular ToxicityAnna Borowiec, Patrycja Ozdowska, Magdalena Rosinska, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|June 5, 2010
Electrocardiographic differentiation between acute pulmonary embolism and non-ST elevation acute coronary syndromes at the bedsideKrzysztof Jankowski, Maciej Kostrubiec, Patrycja Ozdowska, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2025
Coronary Artery Calcium Score as a Predictor of Anthracycline-Induced Cardiotoxicity: The ANTEC StudyAnna Borowiec, Patrycja Ozdowska, Magdalena Rosinska, et al.
International Journal of Molecular Sciences|May 14, 2025
Interleukin-6 in Anthracycline-Related Cardiac Dysfunction: A Comparison with Myeloperoxidase and TNF-AlphaAnna Borowiec, Patrycja Ozdowska, Magdalena Rosinska, et al.
Cardio-Oncology (London, England)|September 28, 2024
Coronary artery calcium score and other risk factors in patients at moderate and high risk of cancer therapy-related cardiovascular toxicityAnna Borowiec, Patrycja Ozdowska, Magdalena Rosinska, et al.
Plos One|August 17, 2023
Prognostic value of coronary atherosclerosis and CAC score for the risk of chemotherapy-related cardiac dysfunction (CTRCD): The protocol of ANTEC studyAnna Borowiec, Patrycja Ozdowska, Magdalena Rosinska, et al.
Pageof 1